Academic staff at Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
Publications
- Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia2021 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Outcome of elderly patients with classical Hodgkin's lymphoma2020 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders2019 | Faculty of Medicine in Hradec Králové
- Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?2015 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a single-center, retrospective study2015 | Faculty of Medicine in Hradec Králové
- Treatment and Prognosis of Relapsed or Refractory Hodgkin Lymphoma Patients Ineligible for Stem Cell Transplantation2014 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Is Severe Cardiac Dysfunction a Contraindication for Complex Combined Oncotherapy of Hodgkin's Lymphoma? Not Any More2013 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: successful treatment with risk-adapted rituximab-based immunochemotherapy2010 | Faculty of Medicine in Hradec Králové
- Achievement of Bcl-2/IgH negativity in peripheral blood/bone marrow is associated with better clinical outcome in patients with follicular lymphoma +12007 | Faculty of Medicine in Hradec Králové
Loading network view...
